Gemcitabine as Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gemcitabine as Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer — Results From the Randomized Phase III SUCCESS-A Trial
Breast Cancer Res 2020 Oct 23;[EPub Ahead of Print], A de Gregorio, L Häberle, PA Fasching, V Müller, I Schrader, R Lorenz, H Forstbauer, TWP Friedl, E Bauer, N de Gregorio, M Deniz, V Fink, I Bekes, U Andergassen, A Schneeweiss, H Tesch, S Mahner, SY Brucker, JU Blohmer, TN Fehm, G Heinrich, K Lato, MW Beckmann, B Rack, W JanniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.